NioBay Confirms Extension of Mineralization on Its Crevier Project and Intersects Rare Earth Elements in Its Northernmost Holes
NBY(NBY) MONTREAL, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce the first results of the 2025 summer drill campaign (the “2025 Campaign”) on the Crevier niobium (Nb) and tantalum (Ta) project (the “Crevier Project”), of which it owns 72.5%. The Crevier Project is located approximately 50 km north of the town of Girardville and approximately 150 km from the Niobec mine. It is located in the Nitassinan (or ancestral territory) of the Pekuakamiulnuatsh, whose main population center is Mashteuiatsh.
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
NBYEMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time special cash dividend of $0.80 per share of common stock. The special cash dividend will be payable on September 29, 2025 to stockholders of record as of the close of business on September 15, 2025.
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
NBYInvestment to support NovaBay’s continued public listing and provide funding for a future strategic transaction
Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction
NovaBay Plans To Hold Virtual Special Meeting On April 16, 2025, At Which Stockholders Will Vote On Proposal For Liquidation And Dissolution
NBYNovaBay Pharma shares are trading lower after the company announced the sale of its Wound Care Trademarks for $500K.
NBYNovaBay Pharmaceuticals Sells Wound Care Trademarks NeutroPhase, PhaseOne, And OmniPhase To Phase One Health For $500K
NBYNovaBay Pharmaceuticals Accepts Revised Offer From PRN Physician Recommended Nutriceuticals, LLC And Enters Into An Amendment To The Asset Purchase Agreement To Increase Purchase Price From $9.5M To $11.5M
NBYNovaBay Pharmaceuticals Stock Is Up 50%: What's Going On?
NBYNovaBay Pharmaceuticals shares are trading higher by 50% Monday afternoon. The marked move higher comes despite a lack of company-specific news for the session.
NovaBay Pharmaceuticals Enters Into Agreements For A Private Placement And Warrant Reprice Transactions To Raise Up To $5.3M
NBYNovaBay Pharmaceuticals's Return On Capital Employed Insights
NBYBenzinga Pro data, NovaBay Pharmaceuticals (AMEX:NBY) reported Q2 sales of $3.04 million. Earnings fell to a loss of $2.15 million, resulting in a 1841.44% decrease from last quarter.
